EMROSI

Journey Medical Corporation🇺🇸 United States

FDA Page

Effective Date: Mar 24, 2025
Approval ID: 0899eb25-8807-037c-f66c-141a2696b1c0
Products: 1 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use EMROSI safely and effectively. See full prescribing information for EMROSI. EMROSI (minocycline hydrochloride) extended-release capsules, for oral use Initial U.S. Approval: 1971

Quick Stats

Total Products1

Labelers2

Label Sections22

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.